Main Menu

Acute Leukaemia Team

The Acute Leukaemia Team aims to develop new therapeutic strategies for acute myeloid leukaemia (AML), a disease with a poor outcome for many patients. The team’s research focusses on improving understanding of the disease through studies on leukaemia stem cells and their interactions with normal haematopoietic stem cells.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.